Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

New discovery could enable scientists to fine-tune activity of cancer-killing immune cells

New discovery could enable scientists to fine-tune activity of cancer-killing immune cells

Pre-existing anticancer drug could help treat common form of heart failure

Pre-existing anticancer drug could help treat common form of heart failure

Discovery could unlock new ways to treat a rare blood disease

Discovery could unlock new ways to treat a rare blood disease

New Distinguished Scholar Award aims to mitigate gender gaps in medical research

New Distinguished Scholar Award aims to mitigate gender gaps in medical research

GW expands clinical trial of neoadjuvant immunotherapy for high-risk cutaneous squamous cell carcinoma

GW expands clinical trial of neoadjuvant immunotherapy for high-risk cutaneous squamous cell carcinoma

Pilot study highlights the effect of chemotherapy on male fertility

Pilot study highlights the effect of chemotherapy on male fertility

Drug profiling and gene editing method open new avenues in the development of CAR T-cell therapy

Drug profiling and gene editing method open new avenues in the development of CAR T-cell therapy

UCR receives $2.2 million grant to target critical oncogenes of B-cell lymphoma 2

UCR receives $2.2 million grant to target critical oncogenes of B-cell lymphoma 2

Research collaboration reveals potential treatment option for incurable blood cancers

Research collaboration reveals potential treatment option for incurable blood cancers

Harmful genetic mutations in healthy donors' stem cells may create problems in AML patients

Harmful genetic mutations in healthy donors' stem cells may create problems in AML patients

Study shows potential new approach to treating two common subtypes of lymphoma

Study shows potential new approach to treating two common subtypes of lymphoma

Bacterial exposure is a potential environmental risk factor in developing coeliac disease

Bacterial exposure is a potential environmental risk factor in developing coeliac disease

Study reveals new mechanism that controls the causes of stomach disease

Study reveals new mechanism that controls the causes of stomach disease

Novel artificial intelligence algorithm helps detect brain tumor

Novel artificial intelligence algorithm helps detect brain tumor

Temperature fluctuations could give early indications of graft-versus-host disease

Temperature fluctuations could give early indications of graft-versus-host disease

Novel imaging technique produces accurate, real-time intraoperative diagnosis of brain tumors

Novel imaging technique produces accurate, real-time intraoperative diagnosis of brain tumors

Recommended amounts of physical activity associated with reduced risk for seven cancers

Recommended amounts of physical activity associated with reduced risk for seven cancers

Scientists develop 3D atlas of bone marrow to help study blood diseases

Scientists develop 3D atlas of bone marrow to help study blood diseases

Scientists create new classification system for tumors

Scientists create new classification system for tumors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.